Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in the Treatment of Cellulitis or Erysipelas
Conditions
Interventions
Daptomycin
Vancomycin
Locations
1
United States
Joseph Still Research Foundation
Augusta, Georgia, United States
Start Date
February 20, 2006
Primary Completion Date
August 9, 2006
Completion Date
August 9, 2006
Last Updated
September 7, 2017
NCT03785834
NCT05624216
NCT01876628
NCT01252719
NCT01671423
NCT04272814
Lead Sponsor
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions